Literature DB >> 22447264

Acute respiratory failure complicating advanced liver disease.

Marcin Karcz1, Bridget Bankey, David Schwaiberger, Burkhard Lachmann, Peter J Papadakos.   

Abstract

Advanced liver disease is associated with hypoxemia and respiratory failure by various mechanisms. Patients with cirrhosis are especially prone to episodes of decompensation requiring intensive care unit admission and management. Such patients may already be in acute liver failure or have decompensated due to a concurrent illness such as spontaneous bacterial peritonitis, sepsis, encephalopathy, varices, or hepatorenal syndrome. Acute respiratory distress syndrome is one of the main reasons for intensive care unit admission and mortality. Overall, critically ill cirrhotic patients frequently progress to multiorgan failure requiring mechanical ventilation. Caring for such patients is therefore understandably complex and extremely challenging. Patients with end-stage liver disease are especially at risk for developing acute respiratory failure and hypoxemia secondary to hepatopulmonary syndrome, portopulmonary hypertension, and hepatic hydrothorax. They should therefore be screened for these conditions because failure to recognize and adequately treat these serious complications of cirrhosis may have devastating consequences. This article is based on a review of the current literature on how to approach and manage acute respiratory failure in advanced liver disease, which is important to intensivists, anesthesiologists, and physicians as a whole. Thieme Medical Publishers 333 Seventh Avenue, New York, NY 10001, USA.

Entities:  

Mesh:

Year:  2012        PMID: 22447264     DOI: 10.1055/s-0032-1301738

Source DB:  PubMed          Journal:  Semin Respir Crit Care Med        ISSN: 1069-3424            Impact factor:   3.119


  8 in total

1.  Efficacy and safety of an open lung ventilation strategy with staircase recruitment followed by comparison on two different modes of ventilation, in moderate ARDS in cirrhosis: A pilot randomized trial.

Authors:  Goel Vibha; Vandana Saluja; Mitra Lalita Gouri; Kumar Guresh; Aggarwal Prashant; Maiwall Rakhi
Journal:  Can J Respir Ther       Date:  2021-07-20

2.  Prescription-acquired acetaminophen use and the risk of asthma in adults: a case-control study.

Authors:  Mugdha Kelkar; Mario A Cleves; Howell R Foster; William R Hogan; Laura P James; Bradley C Martin
Journal:  Ann Pharmacother       Date:  2012-11-20       Impact factor: 3.154

Review 3.  Advances in the management of acute liver failure.

Authors:  Da-Wei Wang; Yi-Mei Yin; Yong-Ming Yao
Journal:  World J Gastroenterol       Date:  2013-11-07       Impact factor: 5.742

Review 4.  Hepatic manifestations and impact of COVID-19 on the cirrhotic patient.

Authors:  J A Velarde-Ruiz Velasco; E S García-Jiménez; J M Remes-Troche
Journal:  Rev Gastroenterol Mex (Engl Ed)       Date:  2020-05-27

5.  Right Atrial Collapse With Hepatic Hydrothorax in Advanced Liver Disease.

Authors:  David L Murphy; Anna E Condino; Matthew J Gittinger; Michael E Vrablik
Journal:  J Med Ultrasound       Date:  2017-04-01

6.  Liver-lung interactions in acute respiratory distress syndrome.

Authors:  Raquel Herrero; Gema Sánchez; Iris Asensio; Eva López; Antonio Ferruelo; Javier Vaquero; Laura Moreno; Alba de Lorenzo; Rafael Bañares; José A Lorente
Journal:  Intensive Care Med Exp       Date:  2020-12-18

Review 7.  Impact of COVID-19 on the Gastrointestinal Tract: A Clinical Review.

Authors:  Haider Ghazanfar; Sameer Kandhi; Dongmin Shin; Aruna Muthumanickam; Hitesh Gurjar; Zaheer A Qureshi; Mohammed Shaban; Mohamed Farag; Asim Haider; Pravash Budhathoki; Tanushree Bhatt; Ali Ghazanfar; Abhilasha Jyala; Harish Patel
Journal:  Cureus       Date:  2022-03-20

8.  Clinical Characteristics and Outcomes of Coronavirus Disease 2019 Among Patients With Preexisting Liver Disease in the United States: A Multicenter Research Network Study.

Authors:  Shailendra Singh; Ahmad Khan
Journal:  Gastroenterology       Date:  2020-05-04       Impact factor: 22.682

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.